Sidley is advising BDT & MSD Partners in connection with their AU$1.6 billion investment in DBG Health, a leading Australian beauty and pharmaceutical company. This strategic investment values DBG Health at approximately AU$7 billion and includes up to AU$1 billion of additional funding for future acquisitions, making this one of the largest private founder-led transactions in Australian corporate history.
The Sidley team is led by David Perkins and Rob Garritano (M&A and Private Equity), and includes Louis Jennings and Adi Milstein (M&A and Private Equity); Noam Waltuch, Rachel Kleinberg, and Andy Lau (Tax); Diane McEnroe, Deeona Gaskin, Susan Stolzer, and Kelly Cho (Food, Drug and Medical Device); Chad Ehrenkranz, George Maliha M.D., and Jenna Hoskison (Healthcare); and Vadim Brusser and Mary Marks (Antitrust and Competition).
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.
